Cardiac troponin I measurement with the ACCESS® immunoassay system: Analytical and clinical performance characteristics

Clinical Chemistry

Volumn 44, Issue 1, 1998, Pages 52-60

  Christenson, Robert H ^a,e   Apple, Fred S ^b   Morgan, David L ^c   Alonsozana, Gladys L ^a   Mascotti, Kristin ^b   Olson, Marilyn ^d   Mccormack, Robert T ^d   Wians Jr , Frank H ^c   Keffer, Joseph H ^c   Duh, Show Hong ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b HENNEPIN COUNTY MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d BECKMAN COULTER INC   (United States)

^e UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC TROPONIN 1; CREATINE KINASE MB; TROPONIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ENZYME ANALYSIS; FEMALE; HEART INFARCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; QUANTITATIVE DIAGNOSIS; RECEIVER OPERATING CHARACTERISTIC;

EID: 6844254515     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/44.1.52     Document Type: Article

References (36)

1. Rusnak RA, Stair TO, Hansen K, Fastow JS. Litigation against the emergency physician: common features in cases of missed myocardial infarction. Ann Emerg Med 1989;18:1029-34.
2. Lee TH, Rouan GW, Weisberg MC, Brand DA, Cook EF. Acampora D, Goldman L. Sensitivity of routine clinical criteria for diagnosing myocardial infarction within 24 h of hospitalization. Ann Intern Med 1987;106:181-6.
3. Fesmire FM, Wharton DR, Calhoun FB. Instability of ST segments in the early stages of acute myocardial infarction in patients undergoing continuous 12-lead ECG monitoring. Am J Emerg Med 1995;13:158-63.
4. Lott JA, Stang JM. Differential diagnosis of patients with abnormal serum creatine kinase isoenzymes. Clin Lab Med 1989;9: 627-42.
5. Gibler WB, Runyon JP, Levy RC, Sayre MR, Kacich R, Hattemer CR, et al. A rapid diagnostic and treatment center for patients with chest pain in the emergency department. Ann Emerg Med 1995; 25:1-8.
6. Apple FS. Acute myocardial infarction and coronary reperfusion. Serum cardiac markers for the 1990's. Am J Clin Pathol 1992; 97:217-26.
7. Lee TH, Rouan GW, Weisberg MC, Brand DA, Cook EF, Acampora D, Goldman L. Sensitivity of routine clinical criteria for diagnosing myocardial infarction within 24 h of hospitalization. Ann Intern Med 1987;106:181-6.
8. Keffer JH. Myocardial markers of injury: evolution and insights. Am J Clin Pathol 1996;105:305-20.
9. Mair J, Dienstl F, Puschendorf B. Cardiac troponin T in the diagnosis of myocardial injury. Crit Rev Clin Lab Sci 1992;29: 31-57.
10. Larue C, Defacque-Lacquement H, Calzolari C, Le Nguyen D, Pau B. New monoclonal antibodies as probes for human cardiac troponin I: epitopic analysis with synthetic peptides. Mol Immunol 1992;29:271-8.
11. Adams JE III, Bodor GS, Davila-Roman VG, Delmez JA, Apple FS, Ladenson JH, Jaffe AS. Cardiac troponin I. A marker with high specificity for cardiac injury. Circulation 1993;88:101-6.
12. Adams JE, Schechtman KB, Landt Y, Ladenson JH, Jaffe AS. Comparable detection of acute myocardial infarction by creatine kinase MB isoenzyme and cardiac troponin I. Clin Chem 1994; 40:1291-5.
13. Wu AHB, Feng YJ, Contois JH, Pervaiz S. Comparison of myoglobin, creatine kinase-MB, and cardiac troponin I for diagnosis of acute myocardial infarction. Ann Clin Lab Sci 1996;26:291-300.
14. Bertinchant JP, Larue C, Pernel I, Ledermann B, Fabbro-Peray P, Beck L, et al. Release kinetics of serum cardiac troponin I in ischemic myocardial injury. Clin Biochem 1996;29:587-93.
15. Newby LK, Gibler WB, Ohman EM, Christenson RH. Biochemical markers in suspected acute myocardial infarction: the need for early assessment [Editorial]. Clin Chem 1995;41:1263-5.
16. Wu AHB, Clive JM. Impact of CK-MB testing policies on hospital length of stay and laboratory costs for patients with myocardial infarction or chest pain. Clin Chem 1997;43:326-32.
17. Hedges JR. Cardiac enzyme availability and hospital length of stay [Editorial]. Clin Chem 1997;43:249-50.
18. Nomenclature: criteria for diagnosis of ischemic heart disease. Report of the International Society and Federation of Cardiology/ World Health Organization Task Force on Standardization of Clinical Nomenclature. Circulation 1979;59:607-9.
19. Larue C, Calzolari C, Bertinchant JP, Leclercq F, Grolleau R, Pau B. Cardiac-specific immunoenzymometric assay of troponin I in the early phase of acute myocardial infarction. Clin Chem 1993;39: 972-9.
20. ® automated analyzer. Clin Chem 1994;40:2042-5.
21. Bodor GS, Porter S, Landt Y, Ladenson JH. The development of monoclonal antibodies and an assay for cardiac troponin-I with preliminary results in suspected myocardial infarction. Clin Chem 1992;11:2203-14.
22. Antman EM, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996;335:1342-1349.
23. ® CK-MB procedure and comparison to electrophoresis and Abbott IMx. Am J Clin Pathol 1996;106:112-7.
24. NCCLS. User evaluation of precision performance of clinical chemistry devices, EP5-T, Vol. 4, No. 8. Wayne, PA: National Committee for Clinical Laboratory Standards, 1992.
25. Dixon WJ, Massey FJ Jr. Enumeration statistics. In: Introduction to statistical analysis, 4th ed. New York: McGraw-Hill, 1983: 288-91.
26. Boyd JC. Mathematical tools for demonstrating the clinical usefulness of biochemical markers. Scand J Clin Lab Invest 1997; 57(Suppl 227):46-63.
27. Adams JE III, Bodor GS, Davila-Roman VG, Delmez JA, Apple FS, Ladenson JH, Jaffe AS. Cardiac troponin I. A marker with high specificity for cardiac injury. Circulation 1993;88:101-6.
28. Adams JE III, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury. Is MB creatine kinase the choice for the 1990's? Circulation 1993;88:750-63.
29. Li D, Jialal I, Keffer J. Greater frequency of increased cardiac troponin T than increased troponin I in patients with renal failure [Letter]. Clin Chem 1996;42:114-5.
30. McLaurin MD, Apple FS, Falahati A, Murakami MM, Miller EA, Sharkey SW. A comparison of cardiac troponin I and CK-MB to rule out myocardial injury in hospitalized patients with renal insufficiency [Abstract]. Circulation 1996;44:173.
31. Bodor GS. Cardiac troponin-I: a highly specific marker for myocardial infarction. J Clin Immunoassay 1994;17:40-4.
32. Guest TM, Ramanathan AV, Tuteur PG, Schechtman KB, Ladenson JH, Jaffe AS. Myocardial injury in critically ill patients. A frequently unrecognized complication. JAMA 1995;273:1945-9.
33. Toyota N, Shimada Y. Differentiation of troponin in cardiac and skeletal muscles in chicken embryos as studied by immunofluorescence microscopy. J Cell Biol 1981;91:497-504.
34. Saggin L, Gorza L, Susoni S, Schiaffino S. Troponin I switching in the developing heart. J Biol Chem 1989;264:16299-302.
35. Bhavsar P, Dhoot GK, Cumming DVE, Butler-Brown GS, Yacoub MH, Barton OJR. Developmental expression of troponin I isoforms in human fetal heart. FEBS Lett 1991;292:5-8.
36. Nagai R, Ueda S, Yazaki Y. RIA of cardiac myosin LC-II in the serum following experimental myocardial infarction. Biochem Biophys Res Commun 1979;86:683.